Blue Water Life Science Advisors, LP 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Blue Water Life Science Advisors, LP disclosed 7 US equity positions worth $100.9m in its Q1 2025 13F filing. The largest position was GH at 29.3% of the reported book, followed by NTRA and ADPT. Against the Q4 2024 filing, it opened 0 new positions, added to 3 and reduced 1 among the top 7 holdings.
What did Blue Water Life Science Advisors, LP own in Q1 2025? Top 7 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | GH GUARDANT HEALTH INC | Healthcare | 29.3% | $29.6m | 694,047 | 0% | held |
| 2 | NTRA NATERA INC | Healthcare | 29.2% | $29.5m | 208,494 | -18% | reduced |
| 3 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 15.8% | $15.9m | 2,145,145 | 0% | held |
| 4 | CDNA CAREDX INC | Healthcare | 12.7% | $12.9m | 724,014 | 20% | added |
| 5 | AKOYA BIOSCIENCES INC | 6.5% | $6.5m | 4,697,785 | 0% | held | |
| 6 | PSNL PERSONALIS INC | Healthcare | 4.1% | $4.1m | 1,175,400 | 4% | added |
| 7 | QTRX QUANTERIX CORP | Healthcare | 2.4% | $2.4m | 372,175 | 375% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.